Orion Oyj operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Orion Oyj with three other
pharmaceutical manufacturers in Europe:
sales of 1.05 billion Euro [US$1.11 billion]
of which 85%
Krka DD Novo Mesto
(1.16 billion Euro [US$1.23 billion]
of which 64%
was European Union), and
Hikma Pharmaceuticals PLC
based in the United Kingdom
(£944.31 million [US$1.18 billion]
of which 49%
was Injectable Pharmaceuticals).
During the year ended December of 2015, sales at
Orion Oyj were 1.02 billion Euro (US$1.07 billion).
a very small
increase of 0.0%
versus 2014, when the company's sales were 1.02 billion Euro.
This was the fifth consecutive year of sales increases at Orion Oyj
(and since 2010, sales have increased a total of 19%).
Sales of Diagnostica saw an increase
that was more than double the company's growth rate: sales were up
2.5% in 2015, from
56.40 million Euro to 57.80 million Euro.
Not all segments of Orion Oyj experienced an increase in sales in 2015:
sales of Pharmaceuticals Business fell 0.1% to 957.80 million Euro.